Developing molecular markers to select the anti-cancer therapies in metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Oxialiplatin-based therapies (FOLFOX, CapeOX), Irinotecan-based therapies (FOLFIRI, IFL, IRIS), Molecular targeting therapies (Bevacizumab, Cetuximab) Mutational analyses of various genes Primary outcome(s): Association between the response rate of anti-cancer drug therapies and genetic alterations Study Design: Parallel Non-randomized
创建时间：
2005-12-15
